Physician profile
Michael S Lowe
NPI 1700834918
$2,872.38
in general payments reported to CMS, 2019-2025
18 companies · $310 in 2025
The $310 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.48 · 2020: $15.58 · 2021: $652 · 2022: $162 · 2023: $1,476 · 2024: $166 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175 · Travel and Lodging: $761 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,175.01 |
| Travel and Lodging | $761.47 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,232.83 | 2022-2025 | Da Vinci Surgical System |
| Stryker Corporation | $483.70 | 2021 | |
| Davol INC. | $348.89 | 2021-2024 | Phasix Mesh |
| Baxter Healthcare | $310.28 | 2022-2025 | Perclot, Tisseel, Artiss |
| Smith+Nephew, INC. | $110.01 | 2021-2025 | Collagenase Santyl, Oasis, Stravix |
| Polynovo North America LLC | $69.19 | 2023-2024 | Novosorb Btm |
| Tei Biosciences INC | $54.78 | 2019 | |
| Solventum Corporation | $42.99 | 2024-2025 | Prevena, Activ.A.C., V.A.C.Ulta |
| Takeda Pharmaceuticals U.S.A., INC. | $31.62 | 2022 | |
| W. L. Gore & Associates, INC. | $25.31 | 2022 | |
| Avita Medical Americas, LLC | $24.05 | 2024 | |
| Kerecis Limited | $23.54 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $23.30 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $22.10 | 2023 | Andexxa |
| Access Pro Medical, LLC | $19.51 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.42 | 2019 | |
| Pfizer INC. | $17.28 | 2019 | |
| Getinge USA Sales, LLC | $15.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.